Williams, Katherine L. http://orcid.org/0000-0003-1657-6795
Guerrero, Steve http://orcid.org/0009-0006-6748-8153
Flores-Garcia, Yevel
Kim, Dongkyoon
Williamson, Kevin S.
Siska, Christine
Smidt, Pauline
Jepson, Sofia Z. http://orcid.org/0000-0003-2435-4906
Li, Kan
Dennison, S. Moses http://orcid.org/0000-0003-1198-9179
Mathis-Torres, Shamika
Chen, Xiaomu
Wille-Reece, Ulrike
MacGill, Randall S. http://orcid.org/0000-0002-4566-1481
Walker, Michael
Jongert, Erik
King, C. Richter
Ockenhouse, Christian
Glanville, Jacob
Moon, James E.
Regules, Jason A.
Tan, Yann Chong
Cavet, Guy
Lippow, Shaun M.
Robinson, William H. http://orcid.org/0000-0003-4385-704X
Dutta, Sheetij
Tomaras, Georgia D. http://orcid.org/0000-0001-8076-1931
Zavala, Fidel http://orcid.org/0000-0002-1414-6196
Ketchem, Randal R. http://orcid.org/0000-0002-7821-2682
Emerling, Daniel E. http://orcid.org/0000-0002-8754-9201
Funding for this research was provided by:
The Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation (INV-001763, INV-008062, INV-008062, INV-008062, OPP1151372, INV008612, OPP1151372, INV008612, INV-001763, OPP1151372, INV008612, INV-001763, INV-008062)
Article History
Received: 10 March 2023
Accepted: 20 October 2023
First Online: 2 January 2024
Competing interests
: W.H.R. owns equity in, serves as a consultant to and is a member of the Board of Directors of Atreca, Inc. K.L.W., S.G., K.S.W. and S.M.L. own equity in, and are employed by, Atreca, Inc. D.E.E. and M.W. own equity in, and serve as consultants to, Atreca, Inc. G.C. and D.K. own equity in Atreca, Inc. C.S., P.S., S.Z.J. and R.R.K. are employed by Just – Evotec Biologics. E.J. owns equity in, and is employed by, GSK. U.W.-R. is employed by BioNTech. J.G. owns equity in, is employed by and is a member of the Board of Directors of Centivax, Inc. Y.C.T. owns equity in Atreca, Inc. and is employed by Nuevocor Pte. Ltd. K.L.W., S.M.L., R.R.K. and D.E.E. are coinventors on patent applications filed by Atreca, Inc. that include antibodies to CSP. The remaining authors declare no competing interests.